STMN3 and central nervous system cancer: Therefore, STMN3 is a consistent eQTL for rs3761124 in early neurological development, in the normal adult brain and in glioma or during gliomagenesis, whereas the RTEL1 expression correlated with rs3761124 only during early neurological development and in IDH1 wild‐type glioma.